# Reflux Disease in Head and Neck Cancer Patients Undergoing Radiation Therapy

> **NCT00928161** · NA · WITHDRAWN · sponsor: **M.D. Anderson Cancer Center**

## Conditions studied

- Head and Neck Cancer
- Oropharyngeal Cancer
- Gastroesophageal Reflux Disease

## Interventions

- **DRUG:** Dexlansoprazole

## Key facts

- **NCT ID:** NCT00928161
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-11
- **Primary completion:** 2014-11
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2012-09-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00928161

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00928161, "Reflux Disease in Head and Neck Cancer Patients Undergoing Radiation Therapy". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00928161. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*